FRANKFURT (Reuters) - German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron ...

Add Yahoo as a preferred source to see more of our stories on Google. People would like to know whether their COVID-19 vaccine is protective enough or a previous infection will keep them safe. Experts ...

WEST PALM BEACH, Fla. — If you've been infected with COVID-19 or got the vaccine, you likely have antibodies. But what does that really tell you? Waking up every day in a pandemic for Leigh Ann David ...

Last week, Adagio Therapeutics raised $80 million in a series B financing to speed its COVID-19 antibody into development. This week, it provided some details about how its approach differs from the ...

Blood collected from survivors of COVID-19 has been used to identify antibodies against the disease, which have been turned into experimental drugs to fight it. But it’s not an easy process. So back ...

FRANKFURT, Dec 14 (Reuters) - German researchers have found that COVID-19 therapies developed by Eli Lilly (LLY.N), opens new tab and Regeneron (REGN.O), opens new tab lose most of their effectiveness ...